In a recent study published in Vaccines, researchers reported on the immunogenicity of a heterologous vaccine regimen against IBV (infectious bronchitis virus), comprising prime doses of QAC ...
TORONTO, Nov. 24, 2020 /CNW/ - IBV Capital Ltd. ("IBV Capital") is pleased to announce that it recently fully realized its equity investment in Ascendant Group Limited ("Ascendant") (BSX: AGL.BH), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results